{"_id": "64fe80191544b4d920499d10", "and": [{"$or": [{"diagnosis": "glioblastoma"}, {"molecular diagnosis": "glioblastoma"}]}, {"$or": [{"genetic abnormalities": "EGFR amplification, whole chromosome 7 gain, whole chromosome 10 loss"}, {"genetic abnormalities": "TERT promoter mutation"}]}, {"tumor recurrence": true}, {"tumor progression": true}, {"$and": [{"tumor size": {"$gte": 1, "$lte": 4}}, {"distance from critical structures": {"$gte": 0.5}}]}, {"surgical cohort": true}, {"MGMT methylation status available": true}, {"$and": [{"time since previous treatments": true}, {"$and": [{"time since previous radiation": {"$gte": 84}}, {"time since previous temozolomide": {"$gte": 21}}, {"time since previous investigational agents": {"$gte": 28}}]}]}, {"age": {"$gte": 18}}, {"Karnofsky performance status": {"$gte": 70}}, {"history and physical examination": true}, {"leukocytes": {"$gte": 2500}}, {"absolute neutrophil count": {"$gte": 1500}}, {"absolute lymphocyte count": {"$gte": 800}}, {"platelets": {"$gte": 100000}}, {"hemoglobin": {"$gte": 8}}, {"total bilirubin": {"$lte": 1.5}}, {"AST": {"$lte": 2.5}}, {"ALT": {"$lte": 2.5}}, {"alkaline phosphatase": {"$lte": 2.5}}, {"creatinine clearance": {"$gte": 30}}, {"$and": [{"contraception": true}, {"negative pregnancy test": true}]}, {"$and": [{"HIV positive": true}, {"$and": [{"undetectable viral load": true}, {"stable HAART regimen": true}, {"no concurrent antibiotics or antifungal agents": true}]}]}, {"$and": [{"HBV viral load undetectable": true}, {"$or": [{"HBV positive": true}, {"immune to hepatitis B": true}]}]}, {"$and": [{"HCV treated and cured": true}, {"HCV viral load undetectable": true}, {"HCV positive": true}]}, {"informed consent": true}, {"prior radiotherapy treatment plan details available": true}], "$not": {"$or": [{"IDH1 or IDH2 mutation": true}, {"germline DNA repair defect": true}, {"diffuse leptomeningeal disease": true}, {"contrast-enhancing tumor in brainstem or spinal cord": true}, {"mass effect or midline shift": true}, {"prior bevacizumab therapy": true}, {"prior or concurrent malignancy": true}, {"prior bone marrow or solid organ transplantation": true}, {"prior treatment with anti-PD-1, anti-PD-L1, or anti-CTLA-4 agents": true}, {"systemic immunostimulatory agents within 4 weeks": true}, {"systemic immunosuppressive medications within 2 weeks": true}, {"systemic corticosteroids > 2 mg of dexamethasone daily within 5 days": true}, {"increased risk for gastrointestinal perforations": true}, {"hypersensitivity to Chinese hamster ovary cell products or recombinant human antibodies": true}, {"severe allergic or hypersensitivity reactions to antibodies or fusion proteins": true}, {"clinically significant liver disease": true}, {"history or risk of autoimmune disease": true}]}}